Cell MedX Corp. reported earnings results for the full year ended May 31, 2023. For the full year, the company reported sales was USD 0.002762 million compared to USD 0.006065 million a year ago.

Net loss was USD 0.495042 million compared to USD 0.697379 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.